Global clinical nutrition market expected to grow to $44.17 billion by 2030 driven by ageing population and rise in chronic diseases

Global Clinical Nutrition Market

Dublin, June 11, 2024 (GLOBE NEWSWIRE) — The “Global Clinical Nutrition Market Size, Share and Trends Analysis Report (By Product (Parenteral, Enteral, Oral), By Application (Malabsorption/Gastrointestinal Disorders/Diarrhea, Oncology), Sales Channel, Region and Segment Forecast, 2024-2030)” report has been published by ResearchAndMarkets.com Recruitment.

The global clinical nutrition market size is expected to reach USD 44.17 billion by 2030, growing at a CAGR of 5.34%. Rising geriatric population and prevalence of chronic diseases, innovations in personalized and targeted solutions, and advancements in healthcare infrastructure are some of the factors driving the market growth.

According to the World Health Organization (WHO), the global population aged 60 and over is expected to surge from about 1 billion in 2020 to about 1.4 billion in 2030, and nearly double to about 2.1 billion by 2050. In recent years, the number of older adults diagnosed with serious health conditions has increased significantly. Moreover, various studies published by the National Center for Biotechnology Information (NCBI) have shown that people aged 65 and over are at higher risk of developing chronic diseases such as Alzheimer’s disease, Parkinson’s disease, and other neurological disorders.

For example, the Alzheimer’s Association reports that of the 5.5 million Americans living with Alzheimer’s disease, an estimated 5.3 million are aged 65 or older. As a result, healthcare professionals are increasingly focusing on optimizing clinical nutrition interventions for the elderly, fueling market growth. Furthermore, the aging process impairs the immune system, increasing vulnerability to infections and affecting vital bodily functions. Myelodysplastic syndromes are characterized by reduced blood cell production, leading to insufficient and immature red blood cells, increasing the risk of infections and anemia-related complications, thus driving the demand for enteral nutrition.

The rising incidence of targeted diseases and advances in drug development are expected to drive the demand for disease-specific formulations. Clinical nutrition is widely used for personalized treatment of diseases such as cystic fibrosis, cancer, etc. Well-known companies such as Nestle specialize in personalized clinical nutrition products such as Deplin for depression and Methanix for diabetes. Deplin differs from commercially available folic acid as it contains already activated folic acid. It should be noted that 70% of patients with depression have a low ability to activate folic acid, hence the demand for medical foods such as Deplin for various non-metabolizing patients is increasing. These factors may drive the demand for clinical nutrition by increasing the effectiveness of treatment and improving the overall quality of medical care.

The COVID-19 pandemic has led to an increased strain on health services and increased susceptibility of critically ill patients to treatment. Patients who test positive for COVID-19 often experience weakened immunity and impaired respiratory and other systems. For example, as highlighted in a publication in Elsevier’s Public Health Emergency Collection, almost half of critically ill COVID-19 patients develop gastrointestinal complications such as hypomotility. In addition, patients experience a range of other abdominal problems, leading to an increased adoption of clinical nutrition at global and national levels.

Moreover, there are numerous studies justifying the use of parenteral nutrition for people with malnutrition issues that have increased during the pandemic, thereby contributing to the expansion of the market. For example, according to an article published in the Journal of the Academy of Nutrition, patients admitted to the ICU for COVID-19 treatment suffered from acute malnutrition. This has led to an increase in the use of parenteral nutrition products in the market during the pandemic.

Various initiatives undertaken by the major players in the market to strengthen their position are positively impacting the market growth. For instance, in March 2023, Danone acquired ProMedica, a Poland-based company that specializes in providing home care services to patients. The acquisition is part of Danone’s lucrative specialty nutrition market expansion strategy to strengthen its presence in Poland. Similarly, in January 2023, Nestle announced an investment of USD 43 million to expand its manufacturing facility in Eau Claire, Wisconsin, USA.

Clinical Nutrition Market Report Highlights

• Based on product, the oral nutrition segment accounted for the largest revenue share of 53.3% in 2023. Rising prevalence of malnutrition in the adult population, increasing cases of obesity, and rise in chronic diseases such as cancer and diabetes are the key factors driving the market growth.

• The parenteral nutrition type segment is projected to grow at the fastest CAGR during the forecast period.

• By application, the oncology segment dominated the market with a revenue share of 15.13% in 2023, while the malabsorption segment is projected to show significant growth throughout the forecast period.

• The institutional distribution channel played a significant role, dominating the distribution channel segment with the largest market share of 45.8% in 2023. On the other hand, the online channel segment is anticipated to manifest the fastest CAGR of 6.15% from 2024 to 2030.

• North America was expected to account for the largest revenue share of 32.62% by 2023, while the Asia Pacific region is expected to grow at the fastest rate due to improving healthcare infrastructure, rising healthcare expenditure, prevalence of premature births, and increasing per capita income.

Key attributes:

Key topics:

Chapter 1. Methodology and Scope

Chapter 2 Overview
2.1. Market outlook
2.2. Outlook by segment
2.3. Competitive Insights

Chapter 3. Clinical Nutrition Market Variables, Trends and Scope
3.1. Market System Outlook
3.2. Price analysis of medical food market
3.3. Industry Analysis
3.4. Technology Outlook
3.5. Regulatory Framework
3.6. Market Trends
3.6.1. Market Factor Analysis
3.6.1.1. Ageing population growth
3.6.1.2. Rise in chronic diseases
3.6.1.3. Increased incidence of cancer
3.6.1.4. Increased risk of malnutrition
3.6.1.5. Changing trends towards disease-specific prescription consumption
3.6.1.6. Increasing demand for enteral nutrition in neonates and preterm infants
3.6.1.7. Increasing organizational strategic efforts to increase market presence
3.6.2. Market constraints analysis
3.6.2.1. Lack of awareness in the medical community
3.6.2.2. Shortage of enteral nutrition products
3.6.2.3. Inappropriate classification of clinical nutrition
3.6.3. Industry Challenges and Opportunities Analysis
3.7. Clinical Nutrition Market Analysis Tools
3.8. Analysis of Major Deals and Strategic Alliances in the Clinical Nutrition Industry
3.9. Impact of COVID-19

Chapter 4. Clinical Nutrition Market: Product Forecast and Trend Analysis
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 and 2030
4.3. Segment Dashboard
4.4. Clinical Nutrition Market by Product, 2018-2030
4.5. Oral Nutrition
4.6. Enteral nutrition
4.7. Enteral nutrition

Chapter 5. Clinical Nutrition Market: Application Estimation and Trend Analysis
5.1. Definition and Scope
5.2. Application market share analysis, 2023 and 2030
5.3. Segment Dashboard
5.4. Clinical Nutrition Market by Application, 2018-2030
Alzheimer’s Disease
5.6. Nutritional deficiencies
Cancer Treatment
Diabetes
Chronic Kidney Disease
5.10. Rare diseases
5.11. Swallowing disorders
Pain Management
5.13. Malabsorption/Gastrointestinal Disorders/Diarrhea
5.14. Other

Chapter 6 Clinical Nutrition Market: Sales Channel Estimation and Trend Analysis
6.1. Definition and Scope
6.2. Sales Channel Market Share Analysis, 2023 and 2030
6.3. Segment Dashboard
6.4. Clinical Nutrition Market by Sales Channel, 2018-2030
6.5. Online Sales Channels
6.6. Retail Sales Channels
6.7. Institutional Distribution Channels

Chapter 7 Clinical Nutrition Market: Regional Estimates and Trend Analysis by Country, Product, Application and Sales Channel
7.1. Definition and Scope
7.2. Market share analysis by region, 2023 and 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
SWOT Analysis
7.6. Clinical Nutrition Market Share by Region, 2023 and 2030 (USD Million)

Chapter 8 Competitive Environment
8.1. Recent developments and impact analysis by major market participants
8.2. Company Classification
8.3. Company Market Share Analysis
8.4. Company Heatmap Analysis
8.5. Strategy Mapping
8.6. Company Profile

• Abbott Nutrition

• Pfizer Japan Inc

• Bayer AG

• Nestle.

• Baxter International Inc.

• Otsuka Holdings Co., Ltd.

• Mead Johnson & Company

• Danone (Nutricia)

• VICTUS Co., Ltd.

• Fresenius Kabi

• Meiji Holdings Co., Ltd.

• AbbVie (Allergan)

• Baxter

• Grifols, S.A.

For more information on this report, please visit: https://www.researchandmarkets.com/r/h0spsc

About ResearchAndMarkets.com
ResearchAndMarkets.com is a leading global source of international market research reports and market data providing the latest information on international markets, regional markets, key industries, top companies, new products and latest trends.

Attachments

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900